Chimeric rhinoviruses as tools for vaccine development and characterization of protein epitopes

Intervirology

Volumn 39, Issue 1-2, 1996, Pages 72-78

  Ferstandig Arnold, Gail ^a   Resnick, Dawn A ^a   Smith, Allen D ^a   Geisler, Sheila C ^a   Holmes, Andrew K ^a   Arnold, Edward ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

AIDS; Chimeric viruses; Combinatorial libraries; Human; Rhinovirus; Vaccines

Indexed keywords

EPITOPE; VIRUS ANTIGEN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ARTICLE; CHIMERA; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; RHINOVIRUS; VACCINATION; VIRUS NEUTRALIZATION; X RAY CRYSTALLOGRAPHY;

EPITOPES; GENE LIBRARY; GENETIC VECTORS; HIV; HUMANS; IMMUNOGENETICS; MUTAGENESIS; REASSORTANT VIRUSES; RHINOVIRUS; VACCINES, SYNTHETIC; VARIATION (GENETICS); VIRAL PROTEINS; VIRAL VACCINES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN RHINOVIRUS SP.; RHINOVIRUS;

EID: 0005111765     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150477     Document Type: Article

References (36)

1. Resnick DA, Smith AD, Geisler SC, Zhang A, Arnold E, Arnold GF: Chimeras from a human rhinovirus 14:human immunodeficiency virus type 1 V3 loop seroprevalence library induce neutralizing responses against HIV-1, J Virol 1995;69:2406-2411.
2. Cease KB, Berzofskv JA; Toward a vaccine for AIDS: The emergence of immunobiology-based vaccine development, Annu Rev Immunol 1994;12:923-989.
3. Gwaltncy JM: Rhinoviruses: in Evans AS (ed): Viral Infections of Humans, Epidemiology and Control, New York, Plenum Medical, 1989, pp 593-615.
4. Couch RM: Rhinoviruses: in Fields BN, et al (eds): Fields Virology, 2, New York, Raven Press, 1990, vol 1, pp 607-629.
5. Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A: A recombinant virus between the Sabin 1 and Sabin 3 strains of poliovirus as a possible candidate lor a new type 3 poliovirus live vaccine strain, J Virol 1988:62:2828- 2835.
6. Martin A, Wychowski C, Couderc T, Crainic R, Hogle J, Girard M: Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice, EMBOJ 1988;7:2829-2847.
7. Murray MG, Bradley J, Yang X-F, Wimmcr E, Moss EG, Racaniello VR: Poliovirus host range is determined by a short amino acid sequence in neutralizing antigenic site I, Science 1988:241:213-215.
8. Li S, Polonis V, Osobe H, Zaghouani H, Guinea R, Moran T, Bona C, Palese P: Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1, J Virol 1993:67:6659- 6666.
9. Muster T, Guinea R, Trkola A, Purtscher M, Klima A, Steindl F, Palese P, Katingcr H: Cross-neutralizing activity against divergent human immunodeficiency virus type I isolates induced by the gp41 sequence ELDKWAS, J Virol 1994:68:4031 -4034.
10. Reimann B-Y, Zell R, Kandolf R: Mappingofa neutralizing antigenic site of coxsackievirus B4 by construction of an antigen chimera. J Virol 1991:65:3475-3480.
11. London SD, Schmaljohn AL, Dalrymple JM, Rice CM: Infectious enveloped RNA virus antigenic chimeras, Proc Natl Acad Sci USA 1992:89:207-211.
12. Hastings GZ, Francis MJ, Rowlands DJ, Chain BM: Antigen processing and presentation of human rhinovirus to CD4 T cells is facilitated by binding to cellular receptors for virus, Eur J Immunol 1993;23:1340-1345.
13. Hastings GZ, Francis MJ, Rowlands DJ, Chain BM: Epitope analysis of the T cell response to a complex antigen: Proliferative responses to human rhinovirus capsids, Eur J Immunol 1993; 23:2300-2305.
14. Rossmann MG, Arnold E, Erickson JW, Fran-kenberger EA, Griffith JP, Hecht H-J, Johnson JE, Karner G, Luo M, Mosser AG, Rueckert RR, Sherry B, Vriend G: Structure of a human common cold virus and functional relationships to other picornaviruses, Nature 1985: 317:145-153.
15. Arnold E, Rossmann MG: Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A, J Mol Biol 1990;211:763-801.
16. Sherry B, Rueckert RR: Evidence for at least two dominant neutralization antigens on human rhinovirus 14, J Virol 1985:53:137-143.
17. Sherry B, Mosser AG, Colonno RJ, Rueckert RR: Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14, J Virol 1986:57:246-257.
18. Davies DR, Sheriffs, Padlan EA: Antibody-antigcn complexes, J Biol C'hcm 1988:263: 10541-10544.
19. Davies DR, Padlan EA, Sheriff S: Antibody-antigen complexes, Annu Rev Biochem 1990: 59:439-473.
20. Wilson IA, Stanfield RL: Antibody-antigen interactions, Curr Opin Struct Biol 1993:3:113-118.
21. Dcdieu J-F, Ronco J, van der Wcrf S, Hogle JM, Henin Y, Girard M: Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1, J Virol 1992;66:3161-3167.
22. Arnold GF, Resnick DA, Li Y, Zhang A, Smith AD, Geisler SC, Jacobo-Molina A, Lee W-M, Webster RG, Arnold E: Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses, Virology 1994:198: 703-708.
23. Evans DJ, McKcating J, Meredith JM, Burke KL, Katrak K, John A, Ferguson M, Minor PD, Weiss RA, Almond JW: An engineered poliovirus chimera elicits broadly reactive HiV-1 neutralizing antibodies, Nature 1989:339:385- 388.
24. Crabbe MJC, Evans DJ, Almond JW: Modelling of poliovirus HIV-1 antigen chimaeras, FEBSLett 1990:271:194-198.
25. Graham BS, Matthews TJ, Belshe RB, Clements ML, Dolin R, Wright PF, Gorse GJ, Schwartz DH, Keefer MC, Bolognesi DP, Corey L, Stablein DM, Esterlitz JR, Hu S-L, Smith GE, Fast PE, Koff WC, Network NAVCT: Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gpl60 recombinant vaccinia and boosting with rgpl60 in vaccinia-naive adults, J Infect Dis 1993:167:533-537.
26. Moore J P, Cao Y, Conley AJ, Wyatt R, Robinson J, Gorny MK, Zolla-Pazner S, Ho DD, Koup RA: Studies with monoclonal antibodies to the V3 region of HIV-1 gpI20 reveal limitations to the utility of solid-phase peptide binding assays, J Acquir Immune DeficSyndr 1994: 7:332-339.
27. Dick EC: Experimental infection of chimpanzees with human rhinovirus types 14 and 43, ProcSoc Exp Biol Med 1968:127:1079-1081.
28. Rini JM, Stanfield RL, Stura EA, Salinas PA, Profy AT, Wilson I A: Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen, Proc Natl Acad Sci USA 1993:90:6325-6329.
29. Arevalo JH, Taussig M, Wilson I: Molecular basis of crossreactivity and the limits of antibody-antigen complementarity, Nature 1993: 365:859-863.
30. Chitarra V, Alzari PM, Bentley GA, Bhat TN, Eisele J-L, Houdusse A, Lescar J, Souchon H, Poljak RJ: Three-dimensional structure of a heteroclitic antigen-antibody cross-reaction complex, Proc Natl Acad Sci USA 1993:90: 7711-7715.
31. Ho DD, Neumann AU, Perclson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature 1995;373:123-126.
32. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection, Nature 1995:373:117- 122.
33. LaRosa GJ, Davide JP, Weinhold K, Waterbu-rv JA, Profy AT, Lewis JA, Langlois AJ, Drees-man GR; Boswell RN, Shadduck P, Holley LH, Karplus M, Bolognesi DP, Matthews TJ, Emini EA, Putney SD: Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant, Science 1990:249:932-935.
34. Myers G, Korvcr B, Berzofskv JA, Smith RF, Pavlakis GN: Human Retroviruses and AIDS, Los Alamos, Los Alamos National Laboratories, 1991.
35. Ohno T, Terada M, Yoneda Y, Shea KW, Chambers RF, Stroka DM, Nakamura M, Kufe DW: A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gpl20, Proc Natl Acad Sci USA 1991,88: 10726-10729.
36. Gomy MK, Conley AJ, Karwowska S, Buch-bindcr A, Xu J-Y, Emini EA, Koenig S, Zolla-Pazner S: Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibodv, J Virol 1992:66:7538-7542.